{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:03:34Z","timestamp":1771707814326,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Fondazione Fiera Milano"},{"name":"Ministero dell'Universit\u00e0, Italy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.expneurol.2011.12.039","type":"journal-article","created":{"date-parts":[[2012,1,2]],"date-time":"2012-01-02T11:58:55Z","timestamp":1325505535000},"page":"230-238","source":"Crossref","is-referenced-by-count":26,"title":["Protective action of NDP-MSH in experimental subarachnoid hemorrhage"],"prefix":"10.1016","volume":"234","author":[{"given":"Stefano","family":"Gatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Lonati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Acerbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio M.","family":"Gaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Catania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.12.039_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/14728221003586836","article-title":"Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy","volume":"14","author":"Aoki","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0010","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1523\/JNEUROSCI.21-13-04668.2001","article-title":"Activation of the nuclear factor-kappaB is a key event in brain tolerance","volume":"21","author":"Blondeau","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.STR.0000053848.06436.AB","article-title":"Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage","volume":"34","author":"Borel","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2007-0027","article-title":"Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases","volume":"29","author":"Brzoska","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.jcbfm.9600283","article-title":"Mechanisms of early brain injury after subarachnoid hemorrhage","volume":"26","author":"Cahill","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0030","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1210\/en.2007-0366","article-title":"Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes","volume":"148","author":"Caruso","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000079321","article-title":"Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats","volume":"79","author":"Caruso","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1189\/jlb.0706426","article-title":"The melanocortin system in leukocyte biology","volume":"81","author":"Catania","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tins.2008.04.002","article-title":"Neuroprotective actions of melanocortins: a therapeutic opportunity","volume":"31","author":"Catania","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.1998.tb08313.x","article-title":"Peptide modulation of fever and inflammation within the brain","volume":"856","author":"Catania","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bbi.2009.04.006","article-title":"Detrimental consequences of brain injury on peripheral cells","volume":"23","author":"Catania","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.peptides.2009.09.030","article-title":"The peptide NDP-MSH induces phenotype changes in the heart that resemble ischemic preconditioning","volume":"31","author":"Catania","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0070","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00701-009-0385-3","article-title":"Role of ERK1\/2 and vascular cell proliferation in cerebral vasospasm after experimental subarachnoid hemorrhage","volume":"151","author":"Chen","year":"2009","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/mvre.1995.1035","article-title":"Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture","volume":"50","author":"de Angelis","year":"1995","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jlb.63.6.740","article-title":"Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia","volume":"63","author":"Delgado","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","article-title":"Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use","volume":"8","author":"Dirnagl","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1227\/01.NEU.0000068863.37133.9E","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation","volume":"53","author":"Dumont","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4419-6354-3_2","article-title":"Melanocortin signalling mechanisms","volume":"681","author":"Eves","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1212\/01.wnl.0000258543.45879.f5","article-title":"Fever after subarachnoid hemorrhage: risk factors and impact on outcome","volume":"68","author":"Fernandez","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4419-6354-3_9","article-title":"Protective effects of melanocortins in systemic host reactions","volume":"681","author":"Gatti","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.06.022","article-title":"Targeting melanocortin receptors as potential novel therapeutics","volume":"111","author":"Getting","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0115","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1210\/en.2005-0692","article-title":"Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia","volume":"147","author":"Giuliani","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2007.05.025","article-title":"Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins","volume":"570","author":"Giuliani","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0125","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.peptides.2005.01.029","article-title":"Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization","volume":"27","author":"Hadley","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tips.2010.11.010","article-title":"Targeting the melanocortin receptor system for anti-stroke therapy","volume":"32","author":"Holloway","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0304-3940(02)01088-1","article-title":"Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice","volume":"334","author":"Huang","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0140","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<684::AID-JNR9>3.0.CO;2-#","article-title":"Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma","volume":"58","author":"Ichiyama","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/exnr.1999.7064","article-title":"Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation","volume":"157","author":"Ichiyama","year":"1999","journal-title":"Exp. Neurol."},{"issue":"Suppl 11","key":"10.1016\/j.expneurol.2011.12.039_bb0150","first-page":"145","article-title":"Mechanisms of vascular dysfunction after subarachnoid hemorrhage","volume":"57","author":"Kozniewska","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0155","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/ar.20970","article-title":"Ischemic tolerance: the mechanisms of neuroprotective strategy","volume":"292","author":"Lehotsky","year":"2009","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0167-5699(97)01009-8","article-title":"Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH","volume":"18","author":"Lipton","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000026335","article-title":"Peptide modulation of inflammatory processes within the brain","volume":"5","author":"Lipton","year":"1998","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0170","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1210\/jc.2005-1411","article-title":"Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype\u2013phenotype relationship, and lack of association with binge eating","volume":"91","author":"Lubrano-Berthelier","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0175","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncpneuro0490","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution","volume":"3","author":"Macdonald","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/jcbfm.2010.62","article-title":"Blockade of the MEK\/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model","volume":"31","author":"Maddahi","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/089771503321532833","article-title":"Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury","volume":"20","author":"Magnoni","year":"2003","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4419-6354-3_3","article-title":"Distribution and function of melanocortin receptors within the brain","volume":"681","author":"Mountjoy","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4419-6354-3_5","article-title":"Melanocortins in brain inflammation: the role of melanocortin receptor subtypes","volume":"681","author":"Muceniece","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.peptides.2005.12.002","article-title":"The MC3 receptor binding affinity of melanocortins correlates with the nitric oxide production inhibition in mice brain inflammation model","volume":"27","author":"Muceniece","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0210","first-page":"165","article-title":"Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models","volume":"52","author":"Prunell","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0215","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1523\/JNEUROSCI.17-06-02181.1997","article-title":"Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation","volume":"17","author":"Rajora","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jlb.59.2.248","article-title":"Alpha-MSH production, receptors, and influence on neopterin in a human monocyte\/macrophage cell line","volume":"59","author":"Rajora","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0225","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1471-4159.2001.00463.x","article-title":"Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB","volume":"78","author":"Ravati","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0230","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1073\/pnas.77.10.5754","article-title":"4-Norleucine, 7-d-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity","volume":"77","author":"Sawyer","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.1999.tb08681.x","article-title":"Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells","volume":"885","author":"Scholzen","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0240","first-page":"R803","article-title":"Central administration of alpha-MSH antiserum augments fever in the rabbit","volume":"250","author":"Shih","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0245","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1073\/pnas.92.17.8016","article-title":"Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone","volume":"92","author":"Star","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2007.04.047","article-title":"The systemic implications of aneurysmal subarachnoid hemorrhage","volume":"261","author":"Stevens","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0255","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1523\/JNEUROSCI.0821-11.2011","article-title":"Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury","volume":"31","author":"Stevens","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI5357","article-title":"Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats","volume":"104","author":"Suzuki","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0265","first-page":"R1289","article-title":"alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte\/macrophages","volume":"276","author":"Taherzadeh","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nbd.2005.06.002","article-title":"Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke","volume":"21","author":"Tang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0275","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00001756-200403010-00022","article-title":"Alpha-MSH inhibits inflammatory signalling in Schwann cells","volume":"15","author":"Teare","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0285","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/STROKEAHA.110.607200","article-title":"Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm","volume":"42","author":"Vellimana","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2011.12.039_bb0290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3171\/jns.2006.105.3.438","article-title":"Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat","volume":"105","author":"Vikman","year":"2006","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2011.12.039_bb0295","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.jcbfm.9600456","article-title":"Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits","volume":"27","author":"Zhou","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T21:55:53Z","timestamp":1561154153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611004912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0014488611004912"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.12.039","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}